Trials / Completed
CompletedNCT02481609
NAC Trial for Anosmia
Pilot Study of Topical Intranasal N-acetyl Cysteine Administration for the Treatment of Anosmia
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to evaluate the use of NAC in the treatment of anosmia (a loss of the sense of smell). This drug is already approved by the Food and Drug Administration (FDA) for oral or pulmonary (lung) inhaled use for other medical conditions. However, there is research evidence that the medication may promote nerve recovery (help nerves work better after they are damaged). Since anosmia involves nerve problems, we believe the nasal spray may help treat anosmia. The medication has been in use for many years for other conditions, without safety problems.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | N-acetyl cysteine (NAC) |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2015-06-25
- Last updated
- 2018-03-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02481609. Inclusion in this directory is not an endorsement.